JMP Group (NYSE:JMP) named Shawn Cross as a managing director in its healthcare investment-banking group with a focus on the biotechnology and biopharmaceutical sectors.
Prior to joining JMP Securities, Mr. Cross was chairman and CEO of GT Biopharma, a clinical-stage immuno-oncology company. Previously, he also was a managing director in healthcare investment banking at Deutsche Bank Securities, where he led the biotechnology coverage effort, after working as a managing director and head of biopharmaceutical investment banking at Well Fargo Securities.
“Shawn brings over two decades of experience to JMP Securities’ healthcare group,” Carter Mack, president of JMP Group, said in a statement. “Shawn’s extensive knowledge of the biotech and biopharma spaces, as well as the associated capital markets and M&A landscapes, will help position our highly regarded life sciences franchise for even greater success.”